{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T15:30:52Z","timestamp":1794324652032,"version":"4.9.0"},"reference-count":0,"publisher":"ScopeMed","issue":"12","license":[{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"vor","delay-in-days":380,"URL":"https:\/\/www.openveterinaryjournal.com\/?sec=licenseinfo"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Open Vet J"],"published-print":{"date-parts":[[2024]]},"abstract":"<jats:p>Background: \nPasteurella multocida is an opportunistic bacterium causes pneumonic pasteurellosis (PP). The common treatment against PP is using antibiotics in conjunction with nonsteroidal anti-inflammatory drugs (NSAIDs). This combination presents various complications, i.e., immune-depression. Hence, the alternative therapy to replace the effects of NSAIDs needs to be clarified. One of them is using fermented calabash (Crescentia cujete (L.)) (FCC). \n\nAim: \nThis study aimed to elucidate the efficacy of FCC in combination with enrofloxacin against artificially induced PP in rat models.\n\nMethods: \nThe calabash was collected and fermented. Moreover, the product of FCC was standardised regarding its biochemical compounds using LC-MS\/MS and HPLC. This study used 30 male Sprague Dawley rats, weight 251.52\u00b12.65 grams, six months old. The rats were divided into six groups as follows: G1 (control); G2 (infected with Pasteurella multocida + untreated); G3 (infected + 20 mg\/kg enrofloxacin); G4 (infected + 20 mg\/kg enrofloxacin + 30 mg\/kg ibuprofen); G5 (infected + 20 mg\/kg enrofloxacin + 2.96 mg\/kg FCC); and G6 (infected + 20 mg\/kg enrofloxacin + 5.92 mg\/kg FCC). The treatment was given once daily for seven days. On day eight, the rats were radiographed. The serum was collected and tested against C-reactive protein (CRP) and procalcitonin. The rats were euthanized and lung tissue was collected for histopathology and immunohistochemistry against CD4+, CD8+ and COX-2. The data was analyzed using SPSS. \n\nResults: \nThis study indicated that FCC contains choline, phytonadione, alpha-tocopherol, and retinol. Moreover, using FCC as a combination therapy with enrofloxacin against PP in group G6 promotes a repair of radiology image compared to other treatments (p&lt;0.05). Group G5 and G6 showed increase activity of BALT, immune expression of CD4+ and COX-2, and the level of CRP and procalcitonin within the lung tissue (p&lt;0.05). Group G6 indicated the better effects in various parameters in this study. However, the FCC has not influenced the immune expression of CD8+ during PP (p&gt;0.05). \n\nConclusion: \nThis study proved that FCC could be used in rat models as an alternative anti-inflammatory treatment in combination with enrofloxacin against PP. Further research is needed to explore other effects of FCC to support the current findings.<\/jats:p>","DOI":"10.5455\/ovj.2024.v14.i12.25","type":"journal-article","created":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T18:39:49Z","timestamp":1736966389000},"page":"3404","source":"Crossref","is-referenced-by-count":6,"title":["&lt;b&gt;The standardization and efficacy of fermented &lt;i&gt;Crescentia cujete&lt;\/i&gt; (L.) in combination with enrofloxacin against artificially induced pneumonic pasteurellosis in rat models&lt;\/b&gt;"],"prefix":"10.5455","volume":"14","author":[{"given":"Yos","family":"Prakoso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achmadi","family":"Susilo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sitarina","family":"Widyarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3407","container-title":["Open Veterinary Journal"],"original-title":[],"link":[{"URL":"https:\/\/www.ejmanager.com\/mnstemps\/100\/100-1727662682.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T18:16:42Z","timestamp":1791483402000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ejmanager.com\/mnstemps\/100\/100-1727662682.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":0,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.5455\/ovj.2024.v14.i12.25","relation":{},"ISSN":["2226-4485"],"issn-type":[{"value":"2226-4485","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]}}}